Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001211662 | SCV001383212 | likely benign | Nemaline myopathy 2 | 2023-05-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001566117 | SCV001789590 | uncertain significance | not provided | 2020-06-01 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function; Not observed at a significant frequency in large population cohorts (Lek et al., 2016) |
Revvity Omics, |
RCV001566117 | SCV003809637 | uncertain significance | not provided | 2020-01-30 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001211662 | SCV002084043 | uncertain significance | Nemaline myopathy 2 | 2020-05-29 | no assertion criteria provided | clinical testing |